angiotensin ii has been researched along with calcitriol in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 11 (57.89) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, K; Fujita, T; Ogata, E; Ono, A; Sato, Y; Shimosawa, T; Takahashi, K | 1 |
| Jahn, H; Miller, R; Omichi, A; Schohn, D | 1 |
| Ando, K; Fujita, T; Shimosawa, T | 1 |
| Bernardi, RJ; Johnson, CS; Modzelewski, RA; Trump, DL | 1 |
| Cao, LP; Chen, ZF; Kong, J; Li, YC; Liu, SQ; Wei, M | 1 |
| Morris, KL; Zemel, MB | 1 |
| Chen, S; Gardner, DG; Grigsby, CL; Law, CS; Olsen, K | 1 |
| Fujii, N; Hamano, T; Hirata, M; Inoue, K; Isaka, Y; Kusunoki, Y; Matsui, I; Nakano, C; Nishiyama, A; Rakugi, H; Shimomura, A; Takabatake, Y; Tsubakihara, Y | 1 |
| Bacca, A; Bernini, G; Bernini, M; Carli, V; Carrara, D; Duranti, E; Ghiadoni, L; Rugani, I; Taddei, S; Virdis, A | 1 |
| Hsu, BG; Lee, CJ; Lee, RP; Liou, HH; Subeq, YM | 1 |
| Inoue, T; Ishii, N; Miyazaki, T; Nishiyama, A; Ohno, Y; Suzuki, H; Takenaka, T | 1 |
| Chen, L; Ding, J; Goltzman, D; Miao, D; Xiao, M; Zhang, L; Zhang, W | 1 |
| Chou, CL; Fang, TC; Lee, TJ; Pang, CY | 1 |
| Collado, A; Gonzalez-Navarro, H; Hueso, L; Martorell, S; Piqueras, L; Sanz, MJ | 1 |
| Gan, H; Xia, Y; Zhao, H | 1 |
| Bi, X; Ding, W; Ling, L; Shen, Q | 1 |
| Astani, A; Jahanifar, F; Jamhiri, M; Safari, F; Shekarforoosh, S; Zarei, F | 1 |
| Dong, J; Gao, M; Li, Y; Liu, Y; Suo, Z; Xu, C | 1 |
| Chacar, S; Fares, N; Hajal, J; Jreije, A; Khouzami, L; Medlej-Hashim, M; Saliba, Y | 1 |
1 trial(s) available for angiotensin ii and calcitriol
| Article | Year |
|---|---|
Effect of acute and chronic vitamin D administration on systemic renin angiotensin system in essential hypertensives and controls.
Topics: Adult; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Calcitriol; Diet, Sodium-Restricted; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypertension; Male; Middle Aged; Receptors, Calcitriol; Renin; Renin-Angiotensin System; Vitamin D | 2013 |
18 other study(ies) available for angiotensin ii and calcitriol
| Article | Year |
|---|---|
Antihypertensive effect of dietary calcium loading in angiotensin II-salt rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Calcitriol; Calcium, Dietary; Electrolytes; Epinephrine; Hypertension; Norepinephrine; Rats; Rats, Inbred Strains | 1991 |
Effects of 1,25(OH)2D3 on cardiovascular function.
Topics: Angiotensin II; Animals; Calcitriol; Calcium; Dogs; Hemodynamics; Isoproterenol; Myocardial Contraction; Norepinephrine; Ventricular Function, Left | 1991 |
Enhancement of vasoconstrictor response by a noncalcemic analogue of vitamin D3.
Topics: 24,25-Dihydroxyvitamin D 3; Angiotensin II; Animals; Blood Pressure; Calcitriol; Calcium; Dose-Response Relationship, Drug; Drug Synergism; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Vasoconstriction | 1993 |
Antiproliferative effects of 1alpha,25-dihydroxyvitamin D(3) and vitamin D analogs on tumor-derived endothelial cells.
Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Blotting, Western; Calcitriol; Carcinoma, Squamous Cell; Cell Division; Dexamethasone; Drug Synergism; Endothelium, Vascular; Gentian Violet; Indicators and Reagents; Mice; Neoplasms; Signal Transduction; Tumor Cells, Cultured; Vitamin D | 2002 |
1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.
Topics: Angiotensin II; Animals; Calcitriol; Drinking Behavior; Gene Expression; Hypertension; Hypocalcemia; In Vitro Techniques; Mice; Mice, Knockout; Neuropeptides; Promoter Regions, Genetic; Receptors, Calcitriol; Renin; Renin-Angiotensin System; RNA, Messenger; Signal Transduction; Sodium, Dietary; Trans-Activators | 2002 |
1,25-dihydroxyvitamin D3 modulation of adipocyte glucocorticoid function.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Adipocytes; Angiotensin II; Calcitriol; Calcium; Calcium, Dietary; Cells, Cultured; Cortisone; Gene Expression; Humans; Hydrocortisone; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction | 2005 |
A role for the cell cycle phosphatase Cdc25a in vitamin D-dependent inhibition of adult rat vascular smooth muscle cell proliferation.
Topics: Angiotensin II; Animals; Calcitriol; cdc25 Phosphatases; Cell Proliferation; Cells, Cultured; Cholecalciferol; Cyclin-Dependent Kinase 2; Endothelins; Muscle, Smooth, Vascular; Rats | 2010 |
Maxacalcitol ameliorates tubulointerstitial fibrosis in obstructed kidneys by recruiting PPM1A/VDR complex to pSmad3.
Topics: Angiotensin II; Animals; Base Sequence; Calcitriol; Cell Line; Extracellular Matrix Proteins; Fibrosis; Immunohistochemistry; Kidney Diseases; Kidney Tubules; Male; Molecular Sequence Data; Phosphoprotein Phosphatases; Phosphorylation; Protective Agents; Protein Phosphatase 2C; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptors, Calcitriol; Renin; RNA, Messenger; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Ureteral Obstruction | 2012 |
Calcitriol decreases TGF-β1 and angiotensin II production and protects against chlorhexide digluconate-induced liver peritoneal fibrosis in rats.
Topics: Angiotensin II; Animals; Calcitriol; Chlorhexidine; Dialysis Solutions; Liver; Male; Muscles; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1 | 2014 |
Calcitriol supplementation improves endothelium-dependent vasodilation in rat hypertensive renal injury.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Calcitriol; Dietary Supplements; Dinoprost; Disease Models, Animal; Endothelium, Vascular; Glucuronidase; Hypertension; Irbesartan; Kidney; Kidney Diseases; Klotho Proteins; Male; Oxidative Stress; Rats; Rats, Inbred SHR; Tetrazoles; Vasodilation; Vitamins | 2014 |
Administration of exogenous 1,25(OH)2D3 normalizes overactivation of the central renin-angiotensin system in 1α(OH)ase knockout mice.
Topics: Acetylcysteine; Angiotensin II; Animals; Antioxidants; Blood Pressure; Brain; Calcitriol; Calcium; Diet; Mice, Knockout; Oxidative Stress; Phosphorus; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Steroid Hydroxylases; Vitamins | 2015 |
Beneficial effects of calcitriol on hypertension, glucose intolerance, impairment of endothelium-dependent vascular relaxation, and visceral adiposity in fructose-fed hypertensive rats.
Topics: Adiposity; Angiotensin II; Animals; Blood Pressure; Body Weight; Calcitriol; Dose-Response Relationship, Drug; Fructose; Glucose Intolerance; Glucose Tolerance Test; Hypertension; Male; Obesity, Abdominal; Rats; Rats, Inbred WKY; Vasodilation; Vitamins | 2015 |
Vitamin D Receptor Activation Reduces Angiotensin-II-Induced Dissecting Abdominal Aortic Aneurysm in Apolipoprotein E-Knockout Mice.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortic Dissection; Apolipoproteins E; Calcitriol; Cells, Cultured; Chemokines; Chemotaxis, Leukocyte; Disease Models, Animal; Genetic Predisposition to Disease; Human Umbilical Vein Endothelial Cells; Humans; Ligands; Macrophages; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinases; Phenotype; Receptors, Calcitriol; Retinoid X Receptor alpha; RNA Interference; Signal Transduction; Transfection; Vascular Endothelial Growth Factor A | 2016 |
Calcitriol Ameliorates AngiotensinII-Induced Renal Injury Partly via Upregulating A20.
Topics: Angiotensin II; Animals; Calcitriol; DNA-Binding Proteins; Epithelial Cells; Kidney; Kidney Tubules; Macrophages; Male; Mice; Necrosis; NF-kappa B; Rats; T-Lymphocytes; Tumor Necrosis Factor alpha-Induced Protein 3; Up-Regulation | 2017 |
1,25-Dihydroxyvitamin D3 Attenuates Angiotensin II-Induced Renal Injury by Inhibiting Mitochondrial Dysfunction and Autophagy.
Topics: Angiotensin II; Animals; Apoptosis; Autophagy; Calcitriol; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; Mitochondria; Vitamins | 2018 |
1.25 Dihydroxyvitamin D3 Attenuates Hypertrophy Markers in Cardiomyoblast H9c2 Cells: Evaluation of Sirtuin3 mRNA and Protein Level.
Topics: Angiotensin II; Animals; Calcitriol; Cardiomegaly; Myocytes, Cardiac; Rats; RNA, Messenger | 2019 |
Calcitriol inhibits COX-1 and COX-2 expressions of renal vasculature in hypertension: Reactive oxygen species involved?
Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Calcitriol; Cyclic N-Oxides; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Endothelium, Vascular; Free Radical Scavengers; Humans; Hypertension; Losartan; NADPH Oxidases; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Receptors, Calcitriol; Renal Artery; Spin Labels; Vasodilation | 2021 |
Calcitriol Supplementation Protects Against Apoptosis and Alleviates the Severity of Abdominal Aortic Aneurysm Induced by Angiotensin II and Anti-TGFβ.
Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Apoptosis; Calcitriol; Dietary Supplements; Disease Models, Animal; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2; Transforming Growth Factor beta | 2022 |